Modalis is a biotech company that develops therapeutics using CRISPR based technology.
Modalis Therapeutics's investors include SBI Investment, Mitsubishi UFJ Capital, Mizuho Capital, SMBC Venture Capital, Fast Track Initiative, Inc..
Modalis Therapeutics is headquartered in Tokyo, Japan.
Modalis is a biotech company that develops therapeutics using CRISPR based technology.
Modalis Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Modalis Therapeutics — Funding & Investors." VCBacked, June 9, 2025, https://www.vcbacked.co/company/modalis-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). Modalis Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/modalis-therapeutics
{{cite web |title=Modalis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/modalis-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated